俄克拉荷马州原住民风湿病患者独特的血清免疫表型与分层
本研究用机器学习方法分析俄克拉荷马州原住民风湿病患者的血清细胞因子、趋化因子和自身抗体,识别出5种免疫表型,可区分不同诊断组并与临床表现相关。血清蛋白特征有望辅助早期诊断和个体化治疗。
要点
- 原住民风湿病患者血清可溶性介质异质性大,反映自身免疫病多样性。
- 随机森林聚类识别出5种免疫表型,涉及慢性炎症、固有免疫、B细胞、Tfh细胞和干扰素通路。
- 低炎症高调节表型者临床表现少,T细胞通路参与表型者关节炎更多。
核心结论
- 血清蛋白特征可将原住民风湿病患者分为不同免疫亚群,可能有助于早期诊断和个体化治疗。
研究设计与样本
- 纳入成人原住民患者,包括自身抗体阳性类风湿关节炎28例、自身抗体阴性类风湿关节炎18例、系统性自身免疫风湿病28例、关节痛/骨关节炎28例、多关节炎/未分化结缔组织病28例及对照28例,检测血清细胞因子、趋化因子和自身抗体,采用随机森林聚类分析。
主要发现
- 不同诊断组间血清可溶性介质不均匀,聚类后形成5种相似免疫表型。
- 慢性炎症及固有免疫、B细胞、滤泡辅助T细胞和干扰素相关通路与调节性特征共同区分5种免疫特征。
- 低炎症和高调节特征患者临床表现较少,T细胞通路参与患者关节炎更多。
关键数值与推荐
- 采用美国风湿病学会系统性风湿病和类风湿关节炎标准评估不同聚类间疾病表现差异。
临床怎么用
- 对原住民风湿病患者可考虑血清免疫表型分层,辅助识别临床表现较少或关节炎更明显的亚群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Native American (NA) populations have higher rates of rheumatic disease and present with overlapping disease symptoms and nontraditional serologic features, thus presenting an urgent need for better biomarkers in NA diagnostics. This study used a machine learning approach to identify immune signatures that more effectively stratify NA patients with rheumatic disease. METHODS: Adult NA patients with autoantibody-positive (AAB+) rheumatoid arthritis (RA; n = 28), autoantibody negative (AAB-) RA (n = 18), systemic autoimmune rheumatic disease (n = 28), arthralgia/osteoarthritis (n = 28), or polyarthritis/undifferentiated connective tissue disease (n = 28), and control patients (n = 28) provided serum samples for cytokine, chemokine, and AAB assessment. Random forest clustering and soluble mediator groups were used to identify patients and control patients with similar biologic signatures. The American College of Rheumatology criteria specific for systemic disease and RA identified differences in disease manifestations across clusters. RESULTS: Serum soluble mediators were not homogenous between different NA rheumatic disease diagnostic groups, reflecting the heterogeneity of autoimmune diseases. Clustering by serum biomarkers created 5 analogous immune phenotypes. Soluble mediators and pathways associated with chronic inflammation and involvement of the innate, B cell, T follicular helper cell, and interferon-associated pathways, along with regulatory signatures, distinguished the 5 immune signatures among patients. Select clinical features were associated with individual immune profiles. Patients with low inflammatory and higher regulatory signatures were more likely to have few clinical manifestations, whereas those with T cell pathway involvement had more arthritis. CONCLUSION: Serum protein signatures distinguished NA patients with rheumatic disease into distinct immune subsets. Following these immune profiles over time may assist with earlier diagnoses and help guide more personalized treatment approaches.
引用
- Slight-Webb S, Guthridge CJ, Kheir J, et al. Unique Serum Immune Phenotypes and Stratification of Oklahoma Native American Rheumatic Disease Patients. Arthritis Care Res (Hoboken). 2022. PMID: 34595847. doi:10.1002/acr.24795
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。